Get the Stockscreener App
19.78
2.28%
0.44
After Hours:
19.78
Puretech Health Plc Adr stock is traded at $19.78, with a volume of 2,295.
It is up +2.28% in the last 24 hours and up +11.12% over the past month.
See More
Previous Close:
$19.34
Open:
$18.5
24h Volume:
2,295
Relative Volume:
0.68
Market Cap:
$425.14M
Revenue:
$1.70M
Net Income/Loss:
$-47.01M
P/E Ratio:
-11.64
EPS:
-1.7
Net Cash Flow:
$-157.28M
1W Performance:
+17.58%
1M Performance:
+11.12%
6M Performance:
-4.05%
1Y Performance:
-30.60%
1-Day Range:
$18.50
$19.78
1-Week Range:
$16.30
$19.78
52-Week Range:
$16.30
$34.00
Puretech Health Plc Adr Stock (PRTC) Company Profile
Name
Puretech Health Plc Adr
Sector
Industry
Phone
-
Address
-
Compare PRTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
19.78 | 425.14M | 1.70M | -47.01M | -157.28M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
Puretech Health Plc Adr Stock (PRTC) Latest News
PureTech Health issues shares to executives after RSU vesting - Investing.com India
PureTech Health issues shares to executives after RSU vesting By Investing.com - Investing.com South Africa
PureTech set for fireside chat at global healthcare event - Investing.com India
PureTech set for fireside chat at global healthcare event By Investing.com - Investing.com South Africa
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
PureTech Health stock hits 52-week low at $16.81 amid market shifts By Investing.com - Investing.com South Africa
PureTech Health stock hits 52-week low at $16.81 amid market shifts - Investing.com India
FDA fast tracks PureTech's leukemia treatment - Investing.com
PureTech to present at J.P. Morgan Healthcare Conference - Investing.com
PureTech reports positive LYT-200 trial results in AML/MDS - Investing.com
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
South Korea Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
PureTech Health (LON:PRTC) Share Price Crosses Below 50-Day Moving Average of $175.96 - Defense World
Asia Pacific Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Europe Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team - Business Wire
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
The definitive Boston biotech layoff tracker for 2023 - The Business Journals
Wall Street Analysts Predict an 82% Upside in PureTech Health PLC Sponsored ADR (PRTC): Here's What You Should Know - Nasdaq
PureTech Announces Annual Results for Year Ended December 31, 2020 - Samoa Observer
Puretech Health Plc Adr Stock (PRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):